
BioMarin Pharmaceutical Inc., founded in 1997, is a global biotechnology company dedicated to transforming lives through genetic discovery. The company specializes in developing targeted therapies that address the root cause of rare genetic diseases, with eight first or best-in-class treatments already commercialized and a pipeline of product candidates for broader genetic disorders. BioMarin's innovative approach combines science-driven research with a patient-centric focus, aiming to impact more lives through its cutting-edge solutions.
BioMarin is seeking a Global Medical Lead, Director level for its Enzyme Conditions portfolio. This leadership role is critical within Global Medical Affairs, reporting to the Medical Lead – ENPP1 Deficiency & LSD. The position focuses on driving strategic medical and clinical development, facilitating regulatory submissions, launching product strategy, and ensuring compliance. The role requires collaboration with various departments to align medical affairs with overall business goals.
BioMarin Pharmaceutical Inc., founded in 1997, is a global biotechnology company dedicated to transforming lives through genetic discovery. The company specializes in developing targeted therapies that address the root cause of rare genetic diseases, with eight first or best-in-class treatments already commercialized and a pipeline of product candidates for broader genetic disorders. BioMarin's innovative approach combines science-driven research with a patient-centric focus, aiming to impact more lives through its cutting-edge solutions.